Timothy Daley
Stock Analyst at Wells Fargo
(2.60)
# 2,109
Out of 4,843 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $47 | $45.13 | +3.43% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $4.19 | +377.33% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $90.42 | +5.07% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $36.70 | +96.19% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $111.92 | +29.56% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,155.52 | +12.50% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $349.24 | -18.39% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $189.90 | +30.07% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $135.63 | +102.76% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $248.97 | +8.45% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $5.86 | +377.82% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $22.21 | +57.59% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $402.82 | +29.09% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $2.60 | +246.15% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $118.07 | +56.69% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $62.17 | +36.72% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $140.33 | +56.77% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $130.28 | +68.87% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $12.91 | +116.89% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $173.34 | -19.23% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $48.40 | +85.95% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $47
Current: $45.13
Upside: +3.43%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $4.19
Upside: +377.33%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $90.42
Upside: +5.07%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $36.70
Upside: +96.19%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $111.92
Upside: +29.56%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,155.52
Upside: +12.50%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $349.24
Upside: -18.39%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $189.90
Upside: +30.07%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $135.63
Upside: +102.76%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $248.97
Upside: +8.45%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $5.86
Upside: +377.82%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $22.21
Upside: +57.59%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $402.82
Upside: +29.09%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $2.60
Upside: +246.15%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $118.07
Upside: +56.69%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $62.17
Upside: +36.72%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $140.33
Upside: +56.77%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $130.28
Upside: +68.87%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $12.91
Upside: +116.89%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $173.34
Upside: -19.23%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $48.40
Upside: +85.95%